Age and First INR After Initiation of Oral Anticoagulant Therapy with Acenocoumarol Predict the Maintenance Dosage

被引：0
作者：
Johanna HH. van Geest-Daalderop
Barbara A. Hutten
Augueste Sturk
Marcel M. Levi
机构：
[1] s-Hertogenbosch,Thrombosis Service
[2] Academic Medical Centre,Departments of Clinical Epidemiology and Biostatistics
[3] Academic Medical Centre,Clinical Chemistry
[4] Academic Medical Centre,Internal Medicine
来源：
Journal of Thrombosis and Thrombolysis | 2003年 / 15卷
关键词：
acenocoumarol; first INR and maintenance dosage; age and maintenance dosage; atrial fibrillation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: This retrospective study was performed to develop a model to predict the maintenance dosage of the vitamin K antagonist acenocoumarol, based upon the first INR after a standard initial dosage regimen.
引用
收藏
页码：197 / 203
页数：6
相关论文
共 79 条
[1]  
Hirsh J(2001)Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 8S-21S
[2]  
Dalen JE(1993)A method to determine the optimal intensity of oral anticoagulation therapy Thromb Haemost 39 236-239
[3]  
Anderson DR(1999)omparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists Thromb Haemost 82 1260-1263
[4]  
Rosendaal FR(1994)Assessment of therapeutical quality control in a long-term anticoagulant trial in post-myocardial infarction patients Thromb Haemost 72 347-351
[5]  
Cannegieter SC(1995)Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 11-17
[6]  
van der Meer FJM(1996)An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 335 540-546
[7]  
Briët E(1993)Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342 1255-1262
[8]  
Hutten BA(1989)Placebo-controlled, randomised trial ofwarfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAKstudy Lancet 1 175-178
[9]  
Prins MH(1991)The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation Final results,Circulation 84 527-539
[10]  
Redekop WK(1990)Canadian atrial fibrillation anticoagulation (CAFA) study N Engl J Med 323 1505-1511
12345678